Logo image of CGRN

CAPSTONE GREEN ENERGY CORP (CGRN) Stock Fundamental Analysis

NASDAQ:CGRN - Nasdaq - US14067D5086 - Common Stock - Currency: USD

0.37  +0.06 (+19.35%)

After market: 0.3011 -0.07 (-18.62%)

Fundamental Rating

1

CGRN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. CGRN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CGRN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CGRN had negative earnings in the past year.
In the past year CGRN has reported a negative cash flow from operations.
In the past 5 years CGRN always reported negative net income.
In the past 5 years CGRN reported 4 times negative operating cash flow.
CGRN Yearly Net Income VS EBIT VS OCF VS FCFCGRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -18.29%, CGRN is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
CGRN has a Return On Equity of -1757.75%. This is amonst the worse of the industry: CGRN underperforms 90.91% of its industry peers.
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROIC N/A
ROA(3y)-22.38%
ROA(5y)-21.03%
ROE(3y)-227.41%
ROE(5y)-158.59%
ROIC(3y)N/A
ROIC(5y)N/A
CGRN Yearly ROA, ROE, ROICCGRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

CGRN has a Gross Margin (14.06%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CGRN has grown nicely.
CGRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y39.37%
CGRN Yearly Profit, Operating, Gross MarginsCGRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 -20 -30

0

2. Health

2.1 Basic Checks

CGRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CGRN has been increased compared to 1 year ago.
CGRN has a worse debt/assets ratio than last year.
CGRN Yearly Shares OutstandingCGRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
CGRN Yearly Total Debt VS Total AssetsCGRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

CGRN has an Altman-Z score of -12.69. This is a bad value and indicates that CGRN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CGRN (-12.69) is worse than 94.32% of its industry peers.
CGRN has a Debt/Equity ratio of 49.90. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 49.90, CGRN is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF N/A
Altman-Z -12.69
ROIC/WACCN/A
WACC8.69%
CGRN Yearly LT Debt VS Equity VS FCFCGRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.70 indicates that CGRN may have some problems paying its short term obligations.
The Current ratio of CGRN (0.70) is worse than 92.05% of its industry peers.
A Quick Ratio of 0.42 indicates that CGRN may have some problems paying its short term obligations.
CGRN has a worse Quick ratio (0.42) than 92.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.42
CGRN Yearly Current Assets VS Current LiabilitesCGRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

4

3. Growth

3.1 Past

CGRN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.58%.
The Revenue has been growing slightly by 4.24% in the past year.
Measured over the past years, CGRN shows a decrease in Revenue. The Revenue has been decreasing by -2.04% on average per year.
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.87%

3.2 Future

The Earnings Per Share is expected to grow by 25.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.71% on average over the next years. This is a very strong growth
EPS Next Y18.64%
EPS Next 2Y34.55%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year4.45%
Revenue Next 2Y7.35%
Revenue Next 3Y6.56%
Revenue Next 5Y27.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGRN Yearly Revenue VS EstimatesCGRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
CGRN Yearly EPS VS EstimatesCGRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -5 -10

1

4. Valuation

4.1 Price/Earnings Ratio

CGRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CGRN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGRN Price Earnings VS Forward Price EarningsCGRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGRN Per share dataCGRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

CGRN's earnings are expected to grow with 25.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.55%
EPS Next 3Y25.33%

0

5. Dividend

5.1 Amount

CGRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPSTONE GREEN ENERGY CORP

NASDAQ:CGRN (10/4/2023, 8:00:00 PM)

After market: 0.3011 -0.07 (-18.62%)

0.37

+0.06 (+19.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)09-25 2023-09-25/amc
Earnings (Next)11-13 2023-11-13/amc
Inst Owners19.26%
Inst Owner ChangeN/A
Ins Owners3.43%
Ins Owner Change0%
Market Cap6.79M
Analysts43.33
Price Target1.58 (327.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.29%
Min EPS beat(2)-110.08%
Max EPS beat(2)-52.51%
EPS beat(4)1
Avg EPS beat(4)-43.37%
Min EPS beat(4)-110.08%
Max EPS beat(4)49.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.62%
Min Revenue beat(2)-14.57%
Max Revenue beat(2)1.33%
Revenue beat(4)1
Avg Revenue beat(4)-11.74%
Min Revenue beat(4)-31.49%
Max Revenue beat(4)1.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-90%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 6.22
P/tB 6.22
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS4.08
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.06%
FCFM N/A
ROA(3y)-22.38%
ROA(5y)-21.03%
ROE(3y)-227.41%
ROE(5y)-158.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y39.37%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 279.68%
Cap/Sales 10.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.42
Altman-Z -12.69
F-Score4
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)333.04%
Cap/Depr(5y)283.07%
Cap/Sales(3y)8.37%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
EPS Next Y18.64%
EPS Next 2Y34.55%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.87%
Revenue Next Year4.45%
Revenue Next 2Y7.35%
Revenue Next 3Y6.56%
Revenue Next 5Y27.71%
EBIT growth 1Y37.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.73%
EBIT Next 3Y38.22%
EBIT Next 5Y33.09%
FCF growth 1Y-128.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.91%
OCF growth 3YN/A
OCF growth 5YN/A